Find trials
Search tips

Follow-up Letters for Subjects in the IRB# 13-001285 "Mayo Clinic Experience with Subjects Diagnosed with Diffuse Large B-cell Lymphoma (DLBCL)" Study

Overview

About this study

The longer follow-up on the subjects will improve the validity on any conclusions made from the IRB study #13-001285.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Subjects in IRB Study number 13-001285 who do not have permissible to use follow-up in their Mayo Medical record since 3/1/2014.

Exclusion Criteria: 

  • Subjects in IRB study number 13-001285 who have permissible to use follow-up follow in their medical record since3/1/2014.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Stephen Ansell, M.D., Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20313730

Mayo Clinic Footer